ARCHIVES

Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds

This article is from The Cancer Letter archive.

Vol. 31 No. 11 | November 28, 2008

Download PDF Visit The Full Archive

Related Articles

Genentech’s Ferrara Wins Lasker Award For VEGF Discovery

October 8, 2010

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

February 20, 1998

Funding Opportunities

March 7, 2003

Komen Foundation Shifts Emphasis To Underserved

May 7, 1993

NCCN Guidelines Retain Avastin For Breast Cancer

October 22, 2010

Low Dose Therapy Improves Survival Of Multiple Myeloma, ECOG Finds; Update At ASCO

May 25, 2007